Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 3
1967 1
1968 8
1970 1
1971 1
1980 1
1982 1
1983 3
1985 2
1986 1
1987 1
1988 4
1989 1
1990 3
1991 1
1992 1
1995 2
1996 2
1997 4
1998 2
1999 2
2000 2
2002 1
2003 3
2004 2
2005 9
2006 11
2007 14
2008 10
2009 8
2010 10
2011 8
2012 13
2013 9
2014 11
2015 9
2016 10
2017 16
2018 14
2019 12
2020 9
2021 8
2022 10
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Results by year

Filters applied: . Clear all
Page 1
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.
Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, Cappuzzo F, Hilgers W, Romano G, Denis F, Viteri S, Debieuvre D, Galetta D, Baldini E, Razaq M, Robinet G, Maio M, Delmonte A, Roch B, Masson P, Schuette W, Zer A, Remon J, Costantini D, Vasseur B, Dziadziuszko R, Giaccone G; ATALANTE-1 study group. Besse B, et al. Among authors: costantini d. Ann Oncol. 2023 Oct;34(10):920-933. doi: 10.1016/j.annonc.2023.07.006. Epub 2023 Sep 11. Ann Oncol. 2023. PMID: 37704166 Free article. Clinical Trial.
Hormesis Promotes Evolutionary Change.
Costantini D. Costantini D. Dose Response. 2019 Apr 24;17(2):1559325819843376. doi: 10.1177/1559325819843376. eCollection 2019 Apr-Jun. Dose Response. 2019. PMID: 31040761 Free PMC article. Review.
Obesity and metabolic comorbidities: environmental diseases?
Lubrano C, Genovesi G, Specchia P, Costantini D, Mariani S, Petrangeli E, Lenzi A, Gnessi L. Lubrano C, et al. Among authors: costantini d. Oxid Med Cell Longev. 2013;2013:640673. doi: 10.1155/2013/640673. Epub 2013 Mar 18. Oxid Med Cell Longev. 2013. PMID: 23577225 Free PMC article. Review.
Novel polyester-polysaccharide nanoparticles.
Lemarchand C, Couvreur P, Besnard M, Costantini D, Gref R. Lemarchand C, et al. Among authors: costantini d. Pharm Res. 2003 Aug;20(8):1284-92. doi: 10.1023/a:1025017502379. Pharm Res. 2003. PMID: 12948027
Rethinking Subthreshold Effects in Regulatory Chemical Risk Assessments.
Agathokleous E, Barceló D, Aschner M, Azevedo RA, Bhattacharya P, Costantini D, Cutler GC, De Marco A, Docea AO, Dórea JG, Duke SO, Efferth T, Fatta-Kassinos D, Fotopoulos V, Ginebreda A, Guedes RNC, Hayes AW, Iavicoli I, Kalantzi OI, Koike T, Kouretas D, Kumar M, Manautou JE, Moore MN, Paoletti E, Peñuelas J, Picó Y, Reiter RJ, Rezaee R, Rinklebe J, Rocha-Santos T, Sicard P, Sonne C, Teaf C, Tsatsakis A, Vardavas AI, Wang W, Zeng EY, Calabrese EJ. Agathokleous E, et al. Among authors: costantini d. Environ Sci Technol. 2022 Aug 16;56(16):11095-11099. doi: 10.1021/acs.est.2c02896. Epub 2022 Jul 25. Environ Sci Technol. 2022. PMID: 35878124 No abstract available.
231 results